₦airaland Forum

our promo is next month again try and take advantage about 12 days to go whatsapp me now to get a ticket to attend and you will get an opportunity to win a free plot of land

my email researche76@GMAil.com

please send me details researche76@gmail.com

50% discount on all our properties buy as low as N150k for a piece of Land at Pertinence Ltd hurry now and enjoy our promo price on all our estate
dont be told you will get free bags of cement and much more so hurry now call Pat on 08098445228

our estates are at various part of Lagos and its environs

All members and none members enjoy quarterly free medical services. These medical services range from, eye test and medications, blood & sugar level examination. malaria checkup. We not only test you but you also get free drugs for more info you can call or whatsapp 08098445228

All members and none members enjoy quarterly free medical services. These medical services range from, eye test and medications, blood & sugar level examination. malaria checkup. We not only test you but you also get free drugs for more info ou can call or whatsapp 08098445228

how explain more

thanks

08098445228

iyablessingcands@gmail.com

Why dont band them let everybody trade with care no job people need to do something

Please call me now for more detail 08098445228

PERTINENCE MAY PROMO

DOES THE THOUGHT OF DEALING WITH OMONILE WAHALA GIVE YOU A NIGHTMARES?

YOU WANT TO START BUILDING THAT DREAM HOUSE OF YOURS BUT YOU JUST CAN’T RAISE N100M TO BUY A PLOT OF LAND or N50M TO BUY A PLOT OF LAND.

SO NOW YOU THINK MAYBE YOU HAVE TO DEAL WITH OMONILE OR REMAIN A TENANT FOREVER IN LAGOS STATE.

DON’T GIVE UP YET.

WE HAVE THE NEXT BIG THING.

LAND PRICES ARE APPRECIATING AS MORE AND MORE PEOPLE ARE BECOMING WISE TO THE INVESTMENT POTENTIAL OF THIS ESTATE.

SO INVEST NOW BUY FROM OUR PROMO PRICE

BELOW ARE PROMO PRICE VERSE THE NORMAL PRICE
FOR MORE DETAILS OR TO BUY CALL PAT 08098445228 OR SEND MESSAGE ON WHATSAPP

shown, in a major breakthrough for regenerative medicine.

For more than a decade scientists have been convinced that stem cells were the future of organ repair because they can become any cell in the body, reversing damage, which was thought to be permanent. Finding new ways to treat organ failure is critical because there is a growing shortage of donor organs in the United Kingdom (UK).

Now, in the largest trial ever conducted, doctors in the United States (U.S.) have shown that even the most serious cases of heart failure can be repaired using stem cells harvested from a patient’s own bone marrow.

End-stage patients, whose only hope was a heart transplant, were treated with stem cells in a single operation. Doctors found the group were 37 per cent less likely to have been admitted to hospital in the 12 months following the operation and half as likely to have died than those on placebo.

According to The Telegraph UK, the procedure takes just two hours and most patients were discharged a day after surgery. The results of the trial were presented at the American College of Cardiology annual meeting and published in The Lancet.

“For the last 15 years everyone has been talking about cell therapy and what it can do. These results suggest that it really works,” says lead author and cardiac surgeon Dr. Amit Pate, director of Cardiovascular Regenerative Medicine at the University of Utah.

“This is the first trial of cell therapy showing that it can have a meaningful impact on the lives of patients with heart failure.”

Heart failure occurs when the heart can no longer pump enough oxygenated blood around the body at the correct pressure, usually because the muscle has become too weak or stiff to work properly.

In the short term it leads to breathlessness, fatigue and swollen ankles but in the long run the major organs will shut down without enough oxygen, eventually leading to death.

Around 900,000 people in the UK have been diagnosed with the condition and up to 40 per cent die within a year.

Drugs to help keep the blood vessels open and lower blood pressure are often prescribed to help manage the condition, but for many patients a heart transplant is the only option. Many die waiting for an organ to become available.

But the researchers say stem cell therapy could one day offer an alternative to a transplant.

The trials involved 126 patients from 31 hospitals across the U.S. Each was assigned stem cell therapy or placebo and the doctors did not know which they would be getting.

A small amount of bone marrow was drawn from each patient from which two types of stem cell were extracted, and their number increased in the lab.

After scanning the patient’s heart to see where the damage was greatest, the stem cells were then delivered to those areas using a catheter.

The groups were then followed for 12 months with doctors monitoring deaths, hospitalisations and unplanned clinic visits. During that period eight patients died who had been given a placebo, compared with four who were on the stem cell treatment. Eighty-two per cent of patients who did not have the therapy needed hospital treatment during that time, compared with 51 per cent of the stem cell patients.

Although the study found there was only very small improvements in overall heart function including performance in an exercise tolerance test, scientists think a larger sample size may show larger benefits and are hoping to move to phase three trials with a greater number of patients.

If you are interested to know more or purchase the products, please WhatsApp: +2348098445228. Thanks

Stem cells can repair a damaged heart and potentially halve the number of people dying from heart failure, scientists have shown, in a major breakthrough for regenerative medicine.

For more than a decade scientists have been convinced that stem cells were the future of organ repair because they can become any cell in the body, reversing damage, which was thought to be permanent. Finding new ways to treat organ failure is critical because there is a growing shortage of donor organs in the United Kingdom (UK).

Now, in the largest trial ever conducted, doctors in the United States (U.S.) have shown that even the most serious cases of heart failure can be repaired using stem cells harvested from a patient’s own bone marrow.

End-stage patients, whose only hope was a heart transplant, were treated with stem cells in a single operation. Doctors found the group were 37 per cent less likely to have been admitted to hospital in the 12 months following the operation and half as likely to have died than those on placebo.

According to The Telegraph UK, the procedure takes just two hours and most patients were discharged a day after surgery. The results of the trial were presented at the American College of Cardiology annual meeting and published in The Lancet.

“For the last 15 years everyone has been talking about cell therapy and what it can do. These results suggest that it really works,” says lead author and cardiac surgeon Dr. Amit Pate, director of Cardiovascular Regenerative Medicine at the University of Utah.

“This is the first trial of cell therapy showing that it can have a meaningful impact on the lives of patients with heart failure.”

Heart failure occurs when the heart can no longer pump enough oxygenated blood around the body at the correct pressure, usually because the muscle has become too weak or stiff to work properly.

In the short term it leads to breathlessness, fatigue and swollen ankles but in the long run the major organs will shut down without enough oxygen, eventually leading to death.

Around 900,000 people in the UK have been diagnosed with the condition and up to 40 per cent die within a year.

Drugs to help keep the blood vessels open and lower blood pressure are often prescribed to help manage the condition, but for many patients a heart transplant is the only option. Many die waiting for an organ to become available.

But the researchers say stem cell therapy could one day offer an alternative to a transplant.

The trials involved 126 patients from 31 hospitals across the U.S. Each was assigned stem cell therapy or placebo and the doctors did not know which they would be getting.

A small amount of bone marrow was drawn from each patient from which two types of stem cell were extracted, and their number increased in the lab.

After scanning the patient’s heart to see where the damage was greatest, the stem cells were then delivered to those areas using a catheter.

The groups were then followed for 12 months with doctors monitoring deaths, hospitalisations and unplanned clinic visits. During that period eight patients died who had been given a placebo, compared with four who were on the stem cell treatment. Eighty-two per cent of patients who did not have the therapy needed hospital treatment during that time, compared with 51 per cent of the stem cell patients.

Although the study found there was only very small improvements in overall heart function including performance in an exercise tolerance test, scientists think a larger sample size may show larger benefits and are hoping to move to phase three trials with a greater number of patients.

If you need stem cell or want to buy our stem cell product call or send whatsapp message to 08098445228

Stem cells can repair a damaged heart and potentially halve the number of people dying from heart failure, scientists have shown, in a major breakthrough for regenerative medicine.

For more than a decade scientists have been convinced that stem cells were the future of organ repair because they can become any cell in the body, reversing damage, which was thought to be permanent. Finding new ways to treat organ failure is critical because there is a growing shortage of donor organs in the United Kingdom (UK).

Now, in the largest trial ever conducted, doctors in the United States (U.S.) have shown that even the most serious cases of heart failure can be repaired using stem cells harvested from a patient’s own bone marrow.

End-stage patients, whose only hope was a heart transplant, were treated with stem cells in a single operation. Doctors found the group were 37 per cent less likely to have been admitted to hospital in the 12 months following the operation and half as likely to have died than those on placebo.

According to The Telegraph UK, the procedure takes just two hours and most patients were discharged a day after surgery. The results of the trial were presented at the American College of Cardiology annual meeting and published in The Lancet.

“For the last 15 years everyone has been talking about cell therapy and what it can do. These results suggest that it really works,” says lead author and cardiac surgeon Dr. Amit Pate, director of Cardiovascular Regenerative Medicine at the University of Utah.

“This is the first trial of cell therapy showing that it can have a meaningful impact on the lives of patients with heart failure.”

Heart failure occurs when the heart can no longer pump enough oxygenated blood around the body at the correct pressure, usually because the muscle has become too weak or stiff to work properly.

In the short term it leads to breathlessness, fatigue and swollen ankles but in the long run the major organs will shut down without enough oxygen, eventually leading to death.

Around 900,000 people in the UK have been diagnosed with the condition and up to 40 per cent die within a year.

Drugs to help keep the blood vessels open and lower blood pressure are often prescribed to help manage the condition, but for many patients a heart transplant is the only option. Many die waiting for an organ to become available.

But the researchers say stem cell therapy could one day offer an alternative to a transplant.

The trials involved 126 patients from 31 hospitals across the U.S. Each was assigned stem cell therapy or placebo and the doctors did not know which they would be getting.

A small amount of bone marrow was drawn from each patient from which two types of stem cell were extracted, and their number increased in the lab.

After scanning the patient’s heart to see where the damage was greatest, the stem cells were then delivered to those areas using a catheter.

The groups were then followed for 12 months with doctors monitoring deaths, hospitalisations and unplanned clinic visits. During that period eight patients died who had been given a placebo, compared with four who were on the stem cell treatment. Eighty-two per cent of patients who did not have the therapy needed hospital treatment during that time, compared with 51 per cent of the stem cell patients.

Although the study found there was only very small improvements in overall heart function including performance in an exercise tolerance test, scientists think a larger sample size may show larger benefits and are hoping to move to phase three trials with a greater number of patients.

If you need stem cell or want to buy our stem cell product call or send whatsapp message to 08098445228

Free plot of Land for our customers this season

Do you know you can win a free plot of land in our forth coming promo sales. For every one that has opportunity to come for our mega promo that will be coming up 23rd of this month April

some lucky winners will go home with free plot of land, others will win an all expense pay trip to Dubai and for those that will make it there that day you will have the opportunity to buy land up to 50% discount that day all you have to do is to buy your ticket now offer last while stock last get your ticket today. To get your ticket just send an email to pertinenceinfo@gmail.com or call 08178703699 or whatsapp 08098445228 and you will get details how you can get your own ticket and the first 10 people to order will get 50% discount of the price of the ticket

Obama's Speech on stem cell research. and how it has the power to cure most chronic diseases

see the video and for more details call Patrick 08178703699



https://www.youtube.com/watch?v=euFa0ETx4wU